TRILAFON IN THE TREATMENT OF CHRONICALLY PSYCHOTIC HOSPITALFZED PATIENTS
HARRY COHEN M. D.1, and
ANNA Z. FREIREICH M. D.2
1 Supervising Psychiatrist, Brooklyn State Hospital, Brooklyn, N. Y.
2 Senior Psychiatrist, Brooklyn State Hospital, Brooklyn, N. Y.
1. Experience with a new " tranquilizer", Trilafon or perphenazine, in treating 90 chronically psychotic hospitalized female patients for a limited period is described.
2. The effects were noted during the period of active administration of the drug and then for a period after termination of the drug therapy. Seventy-two percent of the patients showed some degree of improvement; 15% rose above minimal clinical gains.
3. Side-effects were not serious, were controllable and no deterrent to therapy. The absence of jaundice, blood-dyscrasia and photo-sensitivity are noteworthy.
4. The overall impression is that Trilafon is a useful drug with possibly distinct advantages over the older " tranquilizers" in the treatment of chronically psychotic hospitalized patients.
